Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Adenocarcinoma × gluconic acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 1 Adenocarcinoma 1

Interventions

Fluorouracil 9 Gemcitabine 7 pembrolizumab 6 Irinotecan 6 Paclitaxel 5 Leucovorin 5 Carboplatin 5 Nivolumab 4 Cisplatin 4 130-nm albumin-bound paclitaxel 4 Radiosurgery 3 Pemetrexed 3 Oxaliplatin 3 Albumin-Bound Paclitaxel 3 vandetanib 2 spartalizumab 2 selinexor 2 osimertinib 2 folfirinox 2 Taxes 2 Ramucirumab 2 Radiation 2 Docetaxel 2 Cyclophosphamide 2 Capecitabine 2 Bevacizumab 2 zolbetuximab 1 trastuzumab deruxtecan 1 trametinib 1 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01984580 2013-11-14

Effect of Zinc on Barrett's Metaplasia

Main Line Health

Phase 1 Unknown

Gastrointestinal

Adenocarcinoma, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡